Live Analyst Rating Changes 12299 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Wee Kuang Tay
CI
Wee Kuang Tay
CGS International
Wall Street Analyst
★★★★★
#243
on 13Foresight · ranked by our own returns
85%
Success Rate
+16.3%
Average Return
11 of 13 calls profitable · +5.5% vs benchmark
S&P 500 (SPY)
📈 Across the calls we could measure, roughly 85% of Wee Kuang Tay's ratings turned a profit when each position was held for 2 year — averaging +16.3% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

17 Buy 16 Hold 0 Sell
Wee's Stock Coverage 12 ratings · 2026-07-23
Company Date Position Consensus ⓘ Price Target ⓘ 2-Yr Return vs S&P 500 ⓘ
SG:O39
OCBC
 Jul 21, 2026 HOLD Buy
-32.0% avg upside
9 analysts
$28.40
1.73% Downside
 · ·
SG:D05
DBS Group Holdings
 Jul 21, 2026 BUY Strong Buy
-22.3% avg upside
8 analysts
$77.10
4.90% Upside
 · ·
SG:U11
UOB
 Jul 17, 2026 HOLD Sell
-20.4% avg upside
6 analysts
$42.60
1.02% Downside
 · ·
SG:S58
SATS
 Jun 17, 2026 BUY Strong Buy
-10.2% avg upside
5 analysts
$5.20
10.27% Upside
 +5.5% ·
SG:G13
Genting Singapore
 May 13, 2026 HOLD Buy
+35.4% avg upside
10 analysts
$0.67
8.07% Upside
 +5.0% ·
SG:AIY
iFAST Corporation Ltd
 Apr 27, 2026 BUY Strong Buy
+33.7% avg upside
2 analysts
$13.45
40.48% Upside
 +8.4% ·
SG:P34
Delfi
 Mar 20, 2026 HOLD Hold
+5.9% avg upside
4 analysts
$0.91
4.08% Upside
 -5.6% ·
SG:S68
Singapore Exchange
 Feb 05, 2026 BUY Strong Buy
-29.6% avg upside
8 analysts
$19.10
19.49% Downside
 +37.3% ·
SG:BSL
Raffles Medical Group
 Jan 05, 2026 BUY Strong Buy
+22.5% avg upside
3 analysts
$1.23
28.72% Upside
 -4.0% ·
SG:F34
Wilmar International
 Oct 31, 2025 BUY Buy
-13.6% avg upside
2 analysts
$3.60
6.79% Downside
 +25.9% ·
SG:1J5
Hyphens Pharma International Ltd.
 Sep 11, 2024 BUY Strong Buy
+7.2% avg upside
2 analysts
$0.40
14.38% Upside
 +34.8% ·
IHHHF
IHH Healthcare Bhd
 Aug 30, 2023 BUY Strong Buy
+2.4% avg upside
2 analysts
$1.73
1.40% Upside
 +14.7% ·
🔒 7 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Wee Kuang Tay — Frequently Asked Questions
How accurate are Wee Kuang Tay's stock ratings?
Based on the calls 13Foresight could measure, about 85% of Wee's ratings were profitable over a one-year hold, with an average return of +15.4% per rating, or +7.1% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is Wee ranked on 13Foresight?
Wee Kuang Tay is currently ranked #243 with a 5-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Wee cover?
Wee most recently has ratings on SG:O39, SG:D05, SG:U11, SG:S58, SG:G13, SG:AIY, SG:P34, SG:S68, SG:BSL, SG:F34, SG:1J5, IHHHF. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.